199 related articles for article (PubMed ID: 25447933)
1. Mortality in Parkinson's disease: a 38-year follow-up study.
Pinter B; Diem-Zangerl A; Wenning GK; Scherfler C; Oberaigner W; Seppi K; Poewe W
Mov Disord; 2015 Feb; 30(2):266-9. PubMed ID: 25447933
[TBL] [Abstract][Full Text] [Related]
2. Mortality from Parkinson's disease in China: Findings from a ten-year follow up study in Shanghai.
Zhang Y; Wang C; Wang Y; Xiao Q; Liu J; Ma J; Zhou H; Pan J; Tan Y; Chen S; Xu G; Wang G
Parkinsonism Relat Disord; 2018 Oct; 55():75-80. PubMed ID: 29802079
[TBL] [Abstract][Full Text] [Related]
3. The natural history of Parkinson's disease in the province of Segovia: mortality in a longitudinal study (20-year follow-up).
Duarte J; García Olmos LM; Mendoza A; Clavería LE
Acta Neurol Scand; 2013 May; 127(5):295-300. PubMed ID: 22957805
[TBL] [Abstract][Full Text] [Related]
4. Mortality in Parkinson's disease: a 20-year follow-up study.
Diem-Zangerl A; Seppi K; Wenning GK; Trinka E; Ransmayr G; Oberaigner W; Poewe W
Mov Disord; 2009 Apr; 24(6):819-25. PubMed ID: 19224612
[TBL] [Abstract][Full Text] [Related]
5. The sydney multicentre study of Parkinson's disease: progression and mortality at 10 years.
Hely MA; Morris JG; Traficante R; Reid WG; O'Sullivan DJ; Williamson PM
J Neurol Neurosurg Psychiatry; 1999 Sep; 67(3):300-7. PubMed ID: 10449550
[TBL] [Abstract][Full Text] [Related]
6. Mortality of Alzheimer's Disease Patients: A 10-Year Follow-up Pilot Study in Shanghai.
Zhang YQ; Wang CF; Xu G; Zhao QH; Xie XY; Cui HL; Wang Y; Ren RJ; Guo QH; Wang G
Can J Neurol Sci; 2020 Mar; 47(2):226-230. PubMed ID: 31806074
[TBL] [Abstract][Full Text] [Related]
7. Mortality from Parkinson's disease in China: Findings from a five-year follow up study in Shanghai.
Wang G; Li XJ; Hu YS; Cheng Q; Wang CF; Xiao Q; Liu J; Ma JF; Zhou HY; Pan J; Tan YY; Wang Y; Chen SD
Can J Neurol Sci; 2015 Jul; 42(4):242-7. PubMed ID: 26153040
[TBL] [Abstract][Full Text] [Related]
8. Mortality from Parkinson's disease: a population-based prospective study (NEDICES).
Posada IJ; Benito-León J; Louis ED; Trincado R; Villarejo A; Medrano MJ; Bermejo-Pareja F
Mov Disord; 2011 Dec; 26(14):2522-9. PubMed ID: 21915906
[TBL] [Abstract][Full Text] [Related]
9. Investigation by Parkinson's Disease Research Group of United Kingdom into excess mortality seen with combined levodopa and selegiline treatment in patients with early, mild Parkinson's disease: further results of randomised trial and confidential inquiry.
Ben-Shlomo Y; Churchyard A; Head J; Hurwitz B; Overstall P; Ockelford J; Lees AJ
BMJ; 1998 Apr; 316(7139):1191-6. PubMed ID: 9583926
[TBL] [Abstract][Full Text] [Related]
10. Survival in Parkinson's disease. Relation with motor and non-motor features.
de Lau LM; Verbaan D; Marinus J; van Hilten JJ
Parkinsonism Relat Disord; 2014 Jun; 20(6):613-6. PubMed ID: 24679900
[TBL] [Abstract][Full Text] [Related]
11. Mortality and quality of death certification in a cohort of patients with Parkinson's disease and matched controls in North Wales, UK at 18 years: a community-based cohort study.
Hobson P; Meara J
BMJ Open; 2018 Feb; 8(2):e018969. PubMed ID: 29444783
[TBL] [Abstract][Full Text] [Related]
12. Motor and non-motor function predictors of mortality in Parkinson's disease.
Bugalho P; Ladeira F; Barbosa R; Marto JP; Borbinha C; Salavisa M; da Conceição L; Saraiva M; Fernandes M; Meira B
J Neural Transm (Vienna); 2019 Nov; 126(11):1409-1415. PubMed ID: 31385098
[TBL] [Abstract][Full Text] [Related]
13. The Modifying Effect of Age on Survival in Parkinson's Disease: A Population-Based Cohort Study.
Peretz C; Rozani V; Giladi N; El-Ad B; Tsamir J; Hemo B; Gurevich T
Neuroepidemiology; 2019; 53(1-2):13-19. PubMed ID: 31203291
[TBL] [Abstract][Full Text] [Related]
14. Mortality and cause of death in South Korean patients with Parkinson's disease: a longitudinal follow-up study using a national sample cohort.
Choi HG; Lim JS; Lee YK; Sim S; Kim M
BMJ Open; 2019 Sep; 9(9):e029776. PubMed ID: 31530603
[TBL] [Abstract][Full Text] [Related]
15. Parkinson disease and risk of mortality: a prospective comorbidity-matched cohort study.
Driver JA; Kurth T; Buring JE; Gaziano JM; Logroscino G
Neurology; 2008 Apr; 70(16 Pt 2):1423-30. PubMed ID: 18413567
[TBL] [Abstract][Full Text] [Related]
16. The estimated life expectancy in a community cohort of Parkinson's disease patients with and without dementia, compared with the UK population.
Hobson P; Meara J; Ishihara-Paul L
J Neurol Neurosurg Psychiatry; 2010 Oct; 81(10):1093-8. PubMed ID: 20571039
[TBL] [Abstract][Full Text] [Related]
17. Survival in patients with Parkinson's disease: a ten-year follow-up study in northern China.
Wang S; Li T; Zhou T; Pu L; Wang HY; Yin X; Hao X; Ren L; Liang Z
BMC Neurol; 2022 Sep; 22(1):367. PubMed ID: 36138355
[TBL] [Abstract][Full Text] [Related]
18. Mortality in a population-based cohort of patients treated with antiparkinsonian drugs.
Raschetti R; Spila-Alegiani S; Vanacore N; Ancona C; Meco G
Acta Neurol Scand; 1998 Jan; 97(1):20-6. PubMed ID: 9482674
[TBL] [Abstract][Full Text] [Related]
19. What predicts mortality in Parkinson disease?: a prospective population-based long-term study.
Forsaa EB; Larsen JP; Wentzel-Larsen T; Alves G
Neurology; 2010 Oct; 75(14):1270-6. PubMed ID: 20921512
[TBL] [Abstract][Full Text] [Related]
20. Cognitive Impairment and Mortality in a Population-Based Parkinson's Disease Cohort.
Keener AM; Paul KC; Folle A; Bronstein JM; Ritz B
J Parkinsons Dis; 2018; 8(2):353-362. PubMed ID: 29843251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
